Mrs
Joanna
Pownall

Patent Attorney

Manchester Office

Chemistry

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Joanna graduated from the University of Durham with a First Class MChem Honours degree in Chemistry.

In 2006 Joanna joined a major global pharmaceutical company and worked in their late-stage research and development department firstly as an analytical chemist and then as a solid state scientist. Joanna worked on a number of late stage pharmaceutical projects with multi-discipline project teams. Joanna helped define the solid state strategies, such as the selection of a suitable physical form and the control of the physical form, for a number of projects. Joanna also authored the solid state sections of regulatory submissions.

In September 2014 Joanna joined the in-house IP department of the pharmaceutical company. During her time in this department, Joanna gained experience in patent drafting and prosecution. Joanna was responsible for managing the IP portfolio of a number of early and late-stage pharmaceutical projects.

Joanna joined HGF’s Manchester office in October 2017 and has worked with a number of different clients including pharmaceutical companies and Universities. Joanna has been involved with preparing submissions for opposition and appeal proceedings before the EPO.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
European


MCHEM

MChem in Chemistry

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.